As of 2024-12-14, the Relative Valuation of MEDNAX Inc (MD) is (83.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.07 USD, the upside of MEDNAX Inc based on Relative Valuation is -696.6%.
The range of the Relative Valuation is (86.78) - (85.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.4x - 32.0x | 30.8x |
| Forward P/E multiples | 23.0x - 29.0x | 26.0x |
| Fair Price | (86.78) - (85.60) | (83.94) |
| Upside | -716.8% - -708.4% | -696.6% |
| Date | P/E |
| 2024-12-13 | -4.72 |
| 2024-12-12 | -4.79 |
| 2024-12-11 | -4.80 |
| 2024-12-10 | -4.90 |
| 2024-12-09 | -4.84 |
| 2024-12-06 | -5.01 |
| 2024-12-05 | -4.97 |
| 2024-12-04 | -5.04 |
| 2024-12-03 | -5.01 |
| 2024-12-02 | -5.08 |
| 2024-11-29 | -5.06 |
| 2024-11-27 | -5.00 |
| 2024-11-26 | -4.99 |
| 2024-11-25 | -4.99 |
| 2024-11-22 | -5.06 |
| 2024-11-21 | -4.99 |
| 2024-11-20 | -4.90 |
| 2024-11-19 | -4.94 |
| 2024-11-18 | -4.90 |
| 2024-11-15 | -4.79 |
| 2024-11-14 | -4.99 |
| 2024-11-13 | -5.15 |
| 2024-11-12 | -5.24 |
| 2024-11-11 | -5.40 |
| 2024-11-08 | -5.33 |
| 2024-11-07 | -5.43 |
| 2024-11-06 | -5.44 |
| 2024-11-05 | -5.20 |
| 2024-11-04 | -5.12 |
| 2024-11-01 | -5.15 |
| 2024-10-31 | -4.17 |
| 2024-10-30 | -4.28 |
| 2024-10-29 | -4.39 |
| 2024-10-28 | -4.35 |
| 2024-10-25 | -4.20 |
| 2024-10-24 | -4.25 |
| 2024-10-23 | -4.25 |
| 2024-10-22 | -4.36 |
| 2024-10-21 | -4.31 |
| 2024-10-18 | -4.32 |
| 2024-10-17 | -4.29 |
| 2024-10-16 | -4.28 |
| 2024-10-15 | -4.16 |
| 2024-10-14 | -4.16 |
| 2024-10-11 | -4.10 |
| 2024-10-10 | -4.06 |
| 2024-10-09 | -4.01 |
| 2024-10-08 | -4.00 |
| 2024-10-07 | -4.04 |
| 2024-10-04 | -4.10 |